Clinical Trial Update: Comprehensive Biomarker Profiling of the IFN-α Pathway in Amyotrophic Lateral Sclerosis Patient Biofluids

View source ↗

Summary

Completed clinical trial investigating biomarkers of the interferon-alpha pathway in Amyotrophic Lateral Sclerosis patient biofluids.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Snippet

Sponsor: Ulysses Neuroscience LTD | Conditions: ALS - Amyotrophic Lateral Sclerosis | Status: COMPLETED